ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 507

Level Of Agreement Of The AECG 2002 and ACR 2012 Classification Criteria For Sjögren’s Syndrome In The Brittany Cohort: Clues To Understand Discrepancies

Divi Cornec1, Alain Saraux2, Jacques-Olivier Pers3, Sandrine Jousse-Joulin4, Yves Renaudineau3, Beatrice Cochener5, Thierry Marhadour6 and Valerie Devauchelle-Pensec7, 1Department of rheumatology, Brest Occidentale University, Brest, France, 2Department of rheumatology and unit of immunology (EA 2216), CHU Brest et Université Bretagne Occidentale, Brest, France, 3Unit of immunology, EA 2216, Brest Occidentale University, Brest, France, 4Rheumatology, Brest university medical school, EA 2216, UBO and CHU de la Cavale Blanche,, Brest, France, 5Department of ophtalmology, Brest Occidentale University, Brest, France, 6Rheumatology, CHU de la Cavale Blanche, Brest, France, 7Department of rheumatology and unit of immunology (EA2216), Brest Occidentale university, Brest, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: classification criteria and diagnosis, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: New classification criteria for primary Sjögren’s syndrome (pSS) have been proposed in 2012 and approved by the ACR. They differ substantially from the currently used AECG criteria in that 1) they do not include subjective ocular and buccal symptoms nor functionnal or morphological tests for salivary glands, 2) they use a new Ocular Staining Score (OSS) as the sole evaluation for ocular involvement, and 3) they consider the association of antinuclear antibody (ANA) titer ≥1:320 and rheumatoid factor (RF) positivity as equivalent to anti-SSA/SSB positivity. The aim of this work was to evaluate the agreement between the two sets of criteria, and to determinate the factors leading to an eventual discrepancy.

Methods: This study was conducted in the Brittany monocentric cohort of patients with suspected pSS, included between November 2006 and March 2013. All patients were evaluated by an ophtalmologist who used fluorescein and Lissamine green to evaluate the presence of keratoconjunctivitis sicca, allowing the subsequent calculation of the OSS. All cases were reviewed by a panel of 3 experts, who determined a clinical diagnosis of pSS or other cause of sicca symptoms. The agreement between the different criteria or tests was studied using Cohen’s κ coefficient.

Results: 105 patients have been included in the study. 47 (44.8%) patients had a clinical diagnosis of pSS, 42 (40.0%) fulfilled AECG criteria and 35 (33.3%) ACR criteria. 27 patients fulfilled both classification criteria, 15 patients only AECG, 8 patients only ACR, and 55 none of them. The agreement between the two criteria was moderate (κ = 0.53). Xerophtalmia and xerostomia were noted respectively in 92.4% and 94.3% of the patients, suggesting no discriminating capacity between pSS and non-pSS patients. Only 3 patients had ANA≥1:320 and RF but no anti-SSA, but all of them fulfilled both AECG and ACR criteria. The agreement between OSS ≥3 and Schirmer’s test ≤5mm/5min was very low (κ = 0.14). The agreement with SGB was lower for OSS than for Schirmer’s test (κ = 0.14 and 0.35 respectively); they both displayed poor agreement with SSA/SSB positivity (κ = 0.21 and 0.27 respectively).

Conclusion: ACR 2012 and AECG criteria have a moderate agreement, suggesting that cohorts of pSS patients selected using different classification criteria would not be comparable. The main part of this discrepancy is caused by the differences between OSS and Schirmer’s test. More precise evaluation of the diagnostic value of these ocular tests has to be performed.


Disclosure:

D. Cornec,
None;

A. Saraux,
None;

J. O. Pers,
None;

S. Jousse-Joulin,
None;

Y. Renaudineau,
None;

B. Cochener,
None;

T. Marhadour,
None;

V. Devauchelle-Pensec,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/level-of-agreement-of-the-aecg-2002-and-acr-2012-classification-criteria-for-sjogrens-syndrome-in-the-brittany-cohort-clues-to-understand-discrepancies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology